Merck KGaA
MIL:MRK
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| DE |
|
Merck KGaA
XETRA:MRK
|
54.6B EUR |
Loading...
|
|
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
195.3B USD |
Loading...
|
|
| US |
|
Danaher Corp
NYSE:DHR
|
147.9B USD |
Loading...
|
|
| DE |
|
Basf Se
XETRA:BAS
|
42.5B EUR |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
986.9B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
596.5B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
283.9B CHF |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
247.6B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
238.1B GBP |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
305.9B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
Market Distribution
| Min | -5 776.5% |
| 30th Percentile | 29.1% |
| Median | 44.6% |
| 70th Percentile | 60.9% |
| Max | 184.7% |
Other Profitability Ratios
Merck KGaA
Glance View
In the heart of Darmstadt, Germany, Merck KGaA stands as a testament to innovation and resilience, tracing its roots back to 1668. A bastion of scientific advancement and a pioneer in the world of chemistry and pharmaceuticals, Merck has evolved through centuries of discovery and transformation. Originally a humble pharmacy, Merck has grown into a global powerhouse with a unique structure, being one of the oldest pharmaceutical and chemical companies in the world still owned by the founding family. Though its path has been influenced by numerous historical events, Merck has adeptly navigated the shifting sands of time, transforming itself into a multifaceted conglomerate that thrives on its dual strategy—life sciences and performance materials. In the modern age, Merck KGaA operates through three well-defined sectors: Healthcare, Life Science, and Electronics. Its Healthcare division plays a formidable role, developing innovative drugs, with a focus on oncology, neurology, and immunology, providing cutting-edge treatments that improve patient lives globally. Meanwhile, the Life Science arm caters to researchers and scientists, offering an extensive portfolio of lab materials, high-tech tools, and equipment essential for groundbreaking research across various industries. The Electronics division, dedicated to performance materials, supplies high-quality substances crucial for the electronics and automotive industries, including liquid crystals and highly sophisticated semiconductor solutions. Through these divisions, Merck KGaA not only generates substantial revenue but also drives progress by supplying critical products that are indispensable to the modern technological landscape.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Merck KGaA is 58.7%, which is below its 3-year median of 59.5%.
Over the last 3 years, Merck KGaA’s Gross Margin has decreased from 62.4% to 58.7%. During this period, it reached a low of 58% on Mar 31, 2024 and a high of 62.4% on Sep 30, 2022.